Alemtuzumab Intravenous and Sandostatin LAR Depot
Determining the interaction of Alemtuzumab Intravenous and Sandostatin LAR Depot and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Sandostatin LAR Depot injection
- Alemtuzumab Intravenous-Sani-Supp
- Alemtuzumab Intravenous-Sani-Supp rectal
- Alemtuzumab Intravenous-Sansert
- Alemtuzumab Intravenous-Santyl
- Alemtuzumab Intravenous-Saphris
- Sandostatin LAR Depot-Alenaze-D
- Sandostatin LAR Depot-Alendronate
- Sandostatin LAR Depot-Alendronate and cholecalciferol
- Sandostatin LAR Depot-Alendronate Effervescent Tablets
- Sandostatin LAR Depot-Alendronate Oral Solution
- Sandostatin LAR Depot-Alendronate Sodium